期刊文献+

骨质疏松症m6A甲基化修饰的研究进展

Progress of m6A methylation modification in osteoporosis
原文传递
导出
摘要 N6-甲基腺苷是一种可逆的转录后修饰,在所有真核生物的生命活动中起着重要的调节作用。近年来,研究发现甲基化通过调控RNA的稳定、翻译效率等关键基因,对骨发育和骨稳态进行调节。本综述总结了目前m6A甲基化及其相关调节因子在骨代谢和骨质疏松中的功能作用,以及m6A甲基化相关调控因子作为潜在治疗靶点的重要进展。这些发现将为m6A甲基化在骨质疏松症中的深入研究提供新的方向和认识,也为骨质疏松症的药物治疗提供了新的策略。 N6-methyladenosine(m6A)is a reversible post-transcriptional modification that plays an important regulatory role in the life activities of all eukaryotes.In recent years,m6A methylation has been found to regulate bone development and bone homeostasis by modulating key genes such as RNA stabilization and translation efficiency.In this review,we summarize the current functional roles of m6A methylation and its related regulators in bone metabolism and osteoporosis,as well as the important advances of m6A methylation-related regulators as potential therapeutic targets.These findings will provide new directions and insights into the in-depth study of m6A methylation in osteoporosis,as well as new strategies for the pharmacological treatment of osteoporosis.
作者 陈毅 王耀斌 牛永康 夏亚一 CHEN Yi;WANG Yao-bin;NIU Yong-kang;XIA Ya-yi(Department of Orthopedics,The Second Hospital,Lanzhou University,Lanzhou 730030,China)
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2024年第18期1681-1685,共5页 Orthopedic Journal of China
基金 国家自然科学基金项目(编号:81874017,81960403,82060405) 兰州大学第二医院“萃英科技创新”计划项目(编号:CY2021-MS-A07)。
关键词 m6A 骨质疏松 破骨细胞 成骨细胞 骨髓间充质干细胞 m6A osteoporosis osteoclasts osteoblasts bone marrow mesenchymal stem cells
  • 相关文献

参考文献4

二级参考文献38

  • 1徐伟,盛珺,刘达,郑伟,陈莹,任亚明,蔡云,夏宁.腰椎退变患者骨转换标志物与骨密度及脆性骨折风险的相关性[J].解放军医学杂志,2020,45(2):187-191. 被引量:13
  • 2Ducy P.5-HT and bone biology[J].Curr Opin Pharmacol,2011,11:1-5.
  • 3Gershon MD,Tack J.The serotonin signaling system:from basicunderstanding to drug development for functional GI disorders[J].Gastroenterology,2007,132:397-414.
  • 4Ni W,Watts SW.5-hydroxytryptamine in the cardiovascular sys-tem:focus on the serotonin transporter(SERT)[J].Clin Exp Phar-macol Physiol,2006,33:575-583.
  • 5Collet C,Schiltz C,Geoffroy V.et al.The serotonin 5-HT2B recep-tor controls bone mass via osteoblast recruitment and proliferation[J].Faseb J,2008,2:418-427.
  • 6Ducy P,Karsenty G.The two faces of serotonin in bone biology[J].J Cell Biol,2010,1:7-13.
  • 7Warden SJ,Robling AG,Haney EM,et al.The emerging role ofserotonin(5-hydroxytryptamine)in the skeleton and its mediationof the skeletal effects of low-density lipoprotein receptor-relatedprotein 5(LRP5)[J].Bone,2010,46:4-12.
  • 8Yadav VK,Balaji S,Suresh PS,et al.Pharmacological inhibition ofgut-derived serotonin synthesis is a potential bone anabolic treat-ment for osteoporosis[J].Nat Med,2010,3:308-312.
  • 9Yadav VK,Ducy P.Lrp5 and bone formation a serotonin-depend-ent pathway[J].Ann N Y Acad Sci,2010,1192:103-109.
  • 10Saarinen A,Saukkonen T,KivelT.et al.LDL receptor-relatedprotein 5(LRP5)mutations and osteoporosis,impaired glucose me-tabolism and hypercholesterolaemia[J].Clin Endocrinol(Oxf),2010,72:481-488.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部